Pantoprazol As Kalceks (Pantoprazole)

Pantoprazole, the active ingredient in Pantoprazol As Kalceks, is a proton pump inhibitor presented as a 40 mg tablet for oral use. It reduces gastric acid secretion and is used to treat conditions such as gastro‑oesophageal reflux disease and peptic ulcer disease in adults.

GNH USA supplies Pantoprazol As Kalceks as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Pantoprazole is a proton pump inhibitor that acts on gastric acid‑secretion pathways. It is indicated for several acid‑related gastrointestinal conditions: - Gastro‑oesophageal reflux disease (GERD): provides relief of heartburn and promotes healing of erosive esophagitis. - Peptic ulcer disease: supports ulcer healing and helps prevent recurrence. - Zollinger‑Ellison syndrome: controls excessive gastric acid production associated with gastrin‑secreting tumours. - Erosive esophagitis: aids mucosal healing and symptom control. - NSAID‑induced ulcer prophylaxis: reduces risk of ulcer formation in patients requiring chronic NSAID therapy.

Pantoprazole is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Headache: mild to moderate intensity. - Diarrhea: usually self‑limiting. - Nausea: occasional and transient. - Abdominal pain: mild discomfort. - Flatulence: increased intestinal gas. - Constipation: infrequent.

Serious or Rare Side Effects: - Severe allergic reaction (anaphylaxis): rash, swelling, difficulty breathing. - Clostridioides difficile infection: persistent watery diarrhea. - Low magnesium levels (hypomagnesemia): muscle cramps, irregular heartbeat. - Vitamin B12 deficiency: fatigue, neuropathy with long‑term use. - Bone fractures: increased risk with prolonged therapy. - Acute interstitial nephritis: kidney inflammation presenting with fever and rash.

When prescribing Pantoprazol As Kalceks, clinicians should consider several safety aspects: - Renal impairment: adjust monitoring for patients with reduced kidney function. - Hepatic impairment: use with caution in moderate to severe liver disease. - Long‑term use: evaluate need for continued therapy to avoid nutrient deficiencies. - Drug interactions: review concomitant medications that may affect acid levels or metabolism. - Pregnancy and lactation: assess risk‑benefit ratio before use. - Store at below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Pantoprazole may interact with several medicines, altering their effectiveness or safety profile.

Major Interactions (Avoid): - Ketoconazole or itraconazole: reduced antifungal absorption. - Atazanavir: markedly decreased antiviral exposure. - Clopidogrel: diminished antiplatelet activity.

Moderate Interactions (Monitor Closely): - Warfarin: potential increase in INR; monitor coagulation. - Digoxin: possible rise in serum levels. - Methotrexate: reduced renal clearance; watch for toxicity. - Mycophenolate mofetil: decreased exposure; consider dose adjustment.